How cerebellar support cells (Bergmann glia) may affect Rett syndrome

The Pathophysiological Role of Cerebellar Glia in Rett Syndrome

NIH-funded research Henry Ford Health + Michigan State University Health Sciences · NIH-11251632

Researchers will look at whether problems in specific cerebellar support cells called Bergmann glia cause the movement and social difficulties seen in people with Rett syndrome.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionHenry Ford Health + Michigan State University Health Sciences NIH-funded
Lab location1 site (East Lansing, United States)
Project IDNIH-11251632 on NIH RePORTER

What this research studies

This is a laboratory project that uses mouse models engineered to lack the Rett gene (MECP2) specifically in Bergmann glia, a major glial cell type in the cerebellum, to mimic aspects of Rett syndrome. Scientists will record brain activity with single-unit and local field potential recordings and take detailed intracellular measurements to see how these glia change signaling. They will use genetically encoded sensors to watch calcium, glutamate, and dopamine signals and will apply optogenetics to turn cell activity on or off to test effects on cerebellar circuits. The team aims to link glial dysfunction in the cerebellum to motor and social problems and identify cellular targets that could guide future therapies.

Who could benefit from this research

Good fit: Although this project is preclinical and does not enroll people, it is most relevant to girls and women diagnosed with Rett syndrome caused by MECP2 mutations.

Not a fit: People without MECP2-related Rett syndrome or those seeking immediate clinical treatment are unlikely to receive direct benefit from this laboratory-only project.

Why it matters

Potential benefit: If successful, this work could reveal new cellular targets in the cerebellum that lead to therapies improving movement and social function in people with Rett syndrome.

How similar studies have performed: Prior animal studies have shown that non-neuronal cells can influence Rett-like symptoms, but focusing specifically on cerebellar Bergmann glia and the detailed signaling measures used here is a relatively new and untested approach.

Where this research is happening

East Lansing, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Autistic Disorder
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.